Log in to save to my catalogue

Risperidone-induced prolactin elevation in a prospective study of children, adolescents, and adults...

Risperidone-induced prolactin elevation in a prospective study of children, adolescents, and adults...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_204605240

Risperidone-induced prolactin elevation in a prospective study of children, adolescents, and adults with mental retardation and pervasive developmental disorders

About this item

Full title

Risperidone-induced prolactin elevation in a prospective study of children, adolescents, and adults with mental retardation and pervasive developmental disorders

Publisher

United States: Mary Ann Liebert, Inc

Journal title

Journal of child and adolescent psychopharmacology, 2005-12, Vol.15 (6), p.885-892

Language

English

Formats

Publication information

Publisher

United States: Mary Ann Liebert, Inc

More information

Scope and Contents

Contents

Risperidone is widely prescribed for aggression and self-injury in children, adolescents, and adults with mental retardation (MR) and pervasive developmental disorders (PDD). Risperidone elevates prolactin more than other atypical antipsychotic medications. Females may show greater prolactin elevation than males.
In this relatively long-term stu...

Alternative Titles

Full title

Risperidone-induced prolactin elevation in a prospective study of children, adolescents, and adults with mental retardation and pervasive developmental disorders

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_204605240

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_204605240

Other Identifiers

ISSN

1044-5463

E-ISSN

1557-8992

DOI

10.1089/cap.2005.15.885

How to access this item